‘As we progress in to the 21st hundred years,’ she writes, ‘brand-new treatment schema and products outside of the surgical arena may considerably alter’ current practices. She discovers that current research in the areas of radiology, drug therapeutics, and vaccine development has great potential to change breast cancer management. In radiology, 3-dimensional digital mammography, color doppler ultrasonography, and other even more sophisticated technologies, such as for example magnetic resonance imaging , are being refined to even more accurately identify the size and area of tumors, also to distinguish between malignant and benign lesions. The usage of nanotechnology might provide safer imaging that capitalizes on our growing understanding of specific genes associated with malignancy.Related StoriesResearch provides qualified prospects for new strategies to develop HIV vaccineStudy evaluates efficiency of antiretroviral treatment in HIV-infected childrenDespite reduced HIV/AIDS deaths, disease still persists in South AfricaThe authors indicate the constant risk from observational and ecological research data, and the state guidelines they inspire, as posing a critically important ethical lesson of HPTN 052: whether and what sort of randomized trial should react in light of these. As these necessary changes were produced, they threatened the very research that might support or refute the recommendations themselves, they compose.